Literature DB >> 6450278

Pharmacokinetics and cerebrospinal fluid penetration of moxalactam in children with bacterial meningitis.

S L Kaplan, E O Mason, H Garcia, S J Kvernland, E M Loiselle, D C Anderson, A A Mintz, R D Feigin.   

Abstract

The serum pharmacokinetics and CSF penetration of moxalactam were determined in 39 children with bacterial meningitis. The mean serum concentrations 30 minutes after a 37.5 or 50 mg/kg dose were 66.7 and 113 micrograms/ml, respectively. The t 1/2 beta was between 1.8 and 2.0 hours. The mean +/- 1 SD CSF/serum percentage was 18.5 +/- 16.0% (range 2.0 to 61%) for all children on any day of therapy or hour, after the last of three 50 mg/kg doses. Cerebrospinal fluid bactericidal titers were greater than or equal to 1:32 in 13 of 14 CSF specimens. Moxalactam adequately penetrates into the CSF of children with bacterial meningitis after repetitive 50 mg/kg doses.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6450278     DOI: 10.1016/s0022-3476(81)80562-8

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  28 in total

1.  Aztreonam in the treatment of severe urinary tract infections in pediatric patients.

Authors:  F Rusconi; B M Assael; A Boccazzi; R Colombo; R M Crossignani; L Garlaschi; L Rancilio
Journal:  Antimicrob Agents Chemother       Date:  1986-08       Impact factor: 5.191

2.  Interspecies scaling for the prediction of drug clearance in children: application of maximum lifespan potential and an empirical correction factor.

Authors:  Iftekhar Mahmood
Journal:  Clin Pharmacokinet       Date:  2010-07       Impact factor: 6.447

3.  [Rational parameters in the treatment of bacterial meningitis with modern cephalosporins].

Authors:  O Brückner; M Trautmann
Journal:  Infection       Date:  1987       Impact factor: 3.553

4.  Antimicrobial therapy in newborn infants.

Authors:  M Bhat
Journal:  Indian J Pediatr       Date:  1983 Mar-Apr       Impact factor: 1.967

5.  Comparison of ceftriaxone and traditional therapy of bacterial meningitis.

Authors:  B L Congeni
Journal:  Antimicrob Agents Chemother       Date:  1984-01       Impact factor: 5.191

6.  Treatment of bacterial meningitis with ceftizoxime.

Authors:  G D Overturf; D C Cable; D N Forthal; C Shikuma
Journal:  Antimicrob Agents Chemother       Date:  1984-02       Impact factor: 5.191

7.  Cephalosporins: recent developments.

Authors:  A Kumar
Journal:  J Natl Med Assoc       Date:  1983-02       Impact factor: 1.798

8.  Latamoxef and the newborn.

Authors:  J de Louvois; J James; A Mulhall
Journal:  Arch Dis Child       Date:  1984-04       Impact factor: 3.791

9.  High performance liquid chromatographic determination of moxalactam in human plasma and cerebrospinal fluid.

Authors:  J Nielsen; G Karlaganis; H M von Hattingberg; U B Schaad
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

10.  Single-dose pharmacokinetics of ceftriaxone in infants and young children.

Authors:  U B Schaad; K Stoeckel
Journal:  Antimicrob Agents Chemother       Date:  1982-02       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.